Han Biomedical (ROCO:6999) Long-Term Debt: NT$0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6999 Han Biomedical Inc ROCO:6999
25 GF Score
Price NT$28.45
! 2 Warning Signs
View Full Analysis

What is Han Biomedical Long-Term Debt?

Han Biomedical ROCO:6999 25 Long-Term Debt is NT$0.0 Mil as of Jun. 2026. GuruFocus rates ROCO:6999 with a GF Score™ of 25/100. The stock has 2 warning signs investors should review.

Han Biomedical's Long-Term Debt for the quarter that ended in Jun. 2026 was NT$0.0 Mil.

Han Biomedical  (ROCO:6999) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Han Biomedical Long-Term Debt Related Terms

Han Biomedical Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Han Biomedical's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Han Biomedical Long-Term Debt Chart

Han Biomedical Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
0.00 0.00 0.00 0.00 0.00

Han Biomedical Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:6999
25GF Score
Han Biomedical Inc ROCO:6999
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of NT$0.0 Mil mean?
Han Biomedical (ROCO:6999) has a Long-Term Debt of NT$0.0 Mil as of Jun. 2026.
Is Han Biomedical's Long-Term Debt too high?
Han Biomedical's current Long-Term Debt is NT$0.0 Mil. Overall, Han Biomedical has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Han Biomedical's Long-Term Debt compare to VRTX and REGN?
Han Biomedical's Long-Term Debt of NT$0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Han Biomedical's current Long-Term Debt is NT$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Han Biomedical stock overvalued right now?
Han Biomedical (ROCO:6999) has a current Long-Term Debt of NT$0.0 Mil. The current Long-Term Debt is NT$0.0 Mil. Han Biomedical's overall GF Score™ is 25/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Han Biomedical (ROCO:6999), the current Long-Term Debt is NT$0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Han Biomedical Business Description

Address Xintai 5th Road, 15F-11, No.99, Sec.1, Xizhi District, New Taipei City, TWN
Han Biomedical Inc operates as a bio-material technology platform for the tissue repair market.
25GF Score

Get the complete analysis for ROCO:6999

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$28.45
Price